1. ARIA3001 ARIA3002 and ARIA3003 Study InvestigatorsEfficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia;Urology,2002
2. Efficacy and safety of long-term treatment with the dual 5α-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia;Eur Urol,2004
3. Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia;Int J Urol,2009
4. Effects of dutasteride on lower urinary tract symptoms and general health in men with benign prostatic hypertroplasia and hypogonadism: A prospective study;Aging Male,2014
5. Estimate criteria for diagnosis and severity in benign prostatic hyperplasia;Int J Urol,1996